November 4, 2021 -- Applied Biomath is highlighting two poster presentations being offered at the upcoming Society for Immunotherapy of Cancer (SITC) meeting in Washington, DC.
Company principal scientist David Flowers, PhD, will present a poster titled, "A Computational Semimechanistic Pharmacology Model of ATG-101, a PD-L1/4-1BB Bispecific Antibody for Treatment of Solid Tumors." The work describes the company's collaboration with Antengene on the development of a systems pharmacology model for understanding the treatment's tumor-killing mechanism.
A second poster presentation describes results of the company's collaboration with Genmab and is titled, "Dose Selection for DuoBody-PD-L1×4-1BB (GEN1046) Using a Semimechanistic Pharmacokinetics/Pharmacodynamics Model That Leverages Preclinical and Clinical Data."
The SITC meeting will be held November 10-14, 2021.
Copyright © 2021 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
